跳至主要内容
临床试验/NCT05743920
NCT05743920尚未招募不适用

Efficacy of Self-help Forest Bathing (Shinrin-yoku) on Depression, Anxiety, and Stress: A Pilot Randomized Controlled Trial

Chinese University of Hong Kong0 个研究点目标入组 80 人开始时间: 2023年2月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
Change in the Patient Health Questionnaire (PHQ-9)

研究概览

简要总结

The objective of this pilot randomized controlled trial is to evaluate the efficacy and acceptability of self-help forest bathing on depression, anxiety, and stress in the Hong Kong adult population.

Prior to all study procedures, eligible participants will be required to complete an online informed consent form (with telephone support). Around 80 eligible participants aged between 18 to 65 years old with at least a mild level of depression, anxiety, or stress symptoms will be randomly assigned to either the self-help forest bathing intervention group (FB group) or the waitlist control group (WL group) in a ratio of 1:1.

Participants in the FB group will receive forest bathing guidance via an in-house smartphone app. The WL group will be asked to maintain their typical activity in week 1-7. This group will receive the guide upon trial completion in week 8.

The outcomes of the interest will include generalized anxiety symptoms, depressive symptoms, insomnia symptoms, wellbeing, health-related quality of life, functional impairment at baseline (week 0), immediate (week 7), and 1-month post-intervention assessments (week 10). Treatment credibility and acceptability will be collected at baseline and immediately after the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hong Kong residents;
  • Aged between 18 to 65 years;
  • Meet the threshold for mild depression (score of >5 on the Patient Health Questionnaire 9 [PHQ-9], anxiety (>5 Generalized Anxiety Disorder 7 [GAD-7]), or stress (>15 on the Depression, Anxiety, and Stress Scale [DASS-21] stress subscale, after multiplying score by 2);
  • Able to read and understand Chinese and type in Chinese or English
  • Have an Internet-enabled mobile device (iOS or Android operating system)
  • Willing to provide informed consent and comply with the trial protocol

排除标准

  • Received psychotherapy for depression, anxiety and stress in the past 6 months;
  • A change in psychotropic drugs or over-the-counter medications that target depression, anxiety, and stress within 2 weeks before the baseline assessment.
  • Patient Health Questionnaire-9 (PHQ-9) item 9 score > 2, indicating a moderate level of suicidal risk that requires active crisis management (referral information to professional mental health services will be provided);
  • Currently participating in another intervention study that may potentially affect mental health;
  • Self-disclosure of having unsafe health conditions for which physical activity was contraindicated by physicians;
  • Self-disclosure of any psychiatric, medical, or neurocognitive disorder(s) that makes participation unfeasible;
  • Hospitalization.

结局指标

主要结局

Change in the Patient Health Questionnaire (PHQ-9)

时间窗: Baseline, immediate post-treatment, and 1-month follow-up

The PHQ-9, a 9-item questionnaire used for screening, diagnosing, monitoring, and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day).

次要结局

  • Change in the Sheehan Disability Scale (SDS)(Baseline, immediate post-treatment, and 1-month follow-up)
  • Change in the Credibility-Expectancy Questionnaire (CEQ)(Baseline and immediate post-treatment)
  • Change in the Generalized Anxiety Disorder 7-Item Scale (GAD-7)(Baseline, immediate post-treatment, and 1-month follow-up)
  • Change in the Treatment Acceptability and Adherence Scale (TAAS)(Baseline and immediate post-treatment)
  • Change in the Perceived Stress Scale (PSS)(Baseline, immediate post-treatment, and 1-month follow-up)
  • Change in the Insomnia Severity Index (ISI)(Baseline, immediate post-treatment, and 1-month follow-up)
  • Change in the The World Health Organisation- Five Well-Being Index (WHO-5)(Baseline, immediate post-treatment, and 1-month follow-up)
  • Change in the Short Form (Six-Dimension) Health Survey (SF-6D)(Baseline, immediate post-treatment, and 1-month follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fiona YY Ho

Assistant Professor

Chinese University of Hong Kong

相似试验

Self-help Forest Bathing (Shinrin-yoku) on... | 临床试验